Hikma Ventures
London, Englandhikmaventures.com
Overview
Hikma Ventures is the strategic venture capital arm of Hikma Pharmaceuticals, investing in innovative digital health and life sciences companies worldwide . They invest in disruptive technologies and companies that can make a real difference for Hikma and their portfolio companies . Their investment mandate is broad, with focus areas including drug delivery, digital therapeutics, clinical trial innovation, respiratory, CNS, oncology, and certain autoimmune and chronic diseases .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Octave Bioscience | Sep 2025 | Series C | Co-investor |
| Biolinq | Apr 2025 | Series C | Co-investor |
| i2O Therapeutics | Aug 2023 | Series A | Co-investor |
| Octave Bioscience | Jul 2023 | Series B Extension | Co-investor |
| Prognos Health | May 2023 | Growth Equity | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
